Newsroom

Sorted by: Latest

-

Oritain Upgrades Membership Program with Industry-Leading Turnaround Times, Market Intelligence and Improved Data Access

LONDON--(BUSINESS WIRE)--Oritain, the global leader in forensic origin verification, today announced a major upgrade to its Membership Program, introducing faster turnaround times, new intelligence capabilities and improved access to supply chain insights. The enhanced program is designed to help brands, retailers, manufacturers and suppliers make faster, more confident sourcing, compliance and risk decisions. The launch comes as organisations face increasing pressure to substantiate origin cla...
-

Filigran Accelerates Global Enterprise Growth With Executive Leadership Expansion Across Americas Sales and Cybersecurity

PARIS--(BUSINESS WIRE)--Filigran, the European open-source threat management company, today announced two additions to its leadership team: Tim Durkee as senior vice president of sales, Americas, and Mathieu Rigotto as chief information security officer. The strategic hires come as Filigran experiences rapid international growth following record revenue and platform expansion. Durkee brings more than a decade of experience building enterprise sales organizations and taking cybersecurity and ent...
-

Zai Lab to Present First Global Data from Clinical Trial Evaluating Zocilurtatug Pelitecan (Zoci) As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that global data from a clinical trial evaluating zocilurtatug pelitecan (zoci, formerly ZL-1310) for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC) will be shared for the first time at the European Society for Medical Oncology (ESMO) Congress 2026 taking place October 23-27, 2026, in Madrid. Zoci is a novel, potential first-in-class antibody-drug conjugate (ADC...
-

Où s’envoler? FlightHub dévoile les dernières tendances de voyage qui façonnent 2026

MONTRÉAL--(BUSINESS WIRE)--FlightHubMD, agence de voyages en ligne canadienne de premier plan, publie aujourd’hui la troisième édition de sa liste annuelle « Horizons dévoilés », qui met en lumière les destinations qui gagnent en popularité et les tendances qui façonnent le monde du voyage en 2026. S’appuyant sur des millions de données de recherche et de réservation recueillies entre octobre 2025 et août 2026 et comparées à la même période l’année précédente, le rapport révèle les destinations...
-

Southland Awarded $71 Million Water Pipeline Project in the Southwest 

GRAPEVINE, Texas--(BUSINESS WIRE)--Southland Holdings, Inc. (NYSE American: SLND and SLND WS) (“Southland”) announced today that a subsidiary in its Civil segment, Oscar Renda Contracting, has been awarded a $71 million water pipeline project in the Southwest. The scope of work includes installing approximately 14 miles of 42-inch welded steel water pipeline and trenchless crossings. This award will be included in Southland’s third quarter 2026 backlog. About Southland Southland is a leading pr...
-

Aldeyra Therapeutics Announces Intent to Submit Formal Dispute Resolution Request for Reproxalap to Treat Dry Eye Disease

CONCORD, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced intent to submit to the U.S. Food and Drug Administration (FDA) a Formal Dispute Resolution Request (FDRR) for reproxalap, an investigational drug candidate, for the treatment of dry eye disease. The FDRR, which is expected to be reviewed by the FDA’s Office of New Drug...
-

UF-Led Alzheimer’s Research Center Awarded $22 Million to Accelerate Discoveries; Neuropacs CSO David Vaillancourt to Play Key Scientific Leadership Role

GAINESVILLE, Fla.--(BUSINESS WIRE)--Neuropacs™ Corp. today announced that its Co-Founder & Chief Scientific Officer, Dr. David Vaillancourt, will serve as a key scientific leader in a $22 million National Institutes of Health grant supporting the University of Florida-led Alzheimer’s Disease Research Center (1Florida ADRC). The award positions Florida among a select national network of only 37 ADRCs in the United States and the only one located in the state, expanding the region's role in a...
-

1-800-FLOWERS.COM, Inc. Enters into Definitive Agreement to Sell PersonalizationMall.com® and Things Remembered® to PlanetArt®

JERICHO, N.Y.--(BUSINESS WIRE)--1-800-FLOWERS.COM, Inc. (NASDAQ: FLWS) (the “Company”), a leading provider of thoughtful expressions designed to help inspire customers to give more, connect more, and build more and better relationships, today announced that it has entered into a definitive agreement to sell PersonalizationMall.com and Things Remembered to PlanetArt, LLC, a leading global technology platform for personalized, make on demand e-commerce products, for approximately $45 million in c...
-

World Market Opens New Store in West Jordan, Utah

ALAMEDA, Calif.--(BUSINESS WIRE)--World Market® is proud to announce the opening of its newest store in West Jordan, Utah, marking the retailer’s 250th store nationwide. The new 18,362-square-foot store is located at Jordan Landing, 7037 Plaza Center Drive, West Jordan, Utah 84084. The store will open to the public on October 2, 2026, with grand opening festivities to follow. Store hours are Monday - Saturday 9:00am - 8:00pm and Sunday 10:00am - 7:00pm. The opening of the newest store marks a s...
-

NorthStar Secures Up to $185 Million Growth Financing Led by Hercules Capital to Scale Actinium-225 Production and Radiopharmaceutical Manufacturing for Next-Generation Precision Cancer Therapies

BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Technologies, LLC (NorthStar), the first commercial-scale producer of no-carrier-added actinium-225 (n.c.a. Ac-225) using electron-accelerator technology, today announced a multi-year growth capital facility of up to $185 million with Hercules Capital, Inc. (NYSE: HTGC) to support NorthStar’s continued growth and expansion. The financing, including $100 million upfront, will accelerate investment in isotope production and in clinical and commerci...